|
Pulmonary function on beraprost and placebo treatments in patients with bronchial asthma |
||||
| Run-in |
Placebo |
Washout |
Beraprost |
|
|
|
||||
| FVC as % pred. (%) |
96.8 ± 5.7 |
103.4 ± 3.3 |
104.4 ± 3.1 |
103.4 ± 3.4 |
| FEV1 as% pred. (%) |
90.9 ± 5.7 |
94.1 ± 5.5 |
93.0 ± 5.6 |
93.2 ± 5.6 |
| MMF as% pred. (%) |
50.7 ± 6.7 |
52.0 ± 6.0 |
50.1 ± 6.4 |
51.5 ± 6.4 |
|
Data are shown as standard error of the mean for FVC, FEV1 and MMF. * p < 0.05 compared with each control value (Wilcoxon signed-ranks test). | ||||
Ishiura et al. Cough 2007 3:2 doi:10.1186/1745-9974-3-2 |
||||